Diagnostics company Thyrocare Technologies will list its shares on the bourses tomorrow. File Photo
Diagnostics company Thyrocare Technologies, which recently concluded its IPO, will list its shares on the bourses tomorrow.
“Effective from Monday, May 9, 2016, the equity shares of Thyrocare Technologies shall be listed and admitted to dealings on the exchange,” BSE had said in a notice earlier this week.
The initial public offering (IPO) of Thyrocare was oversubscribed 73.55 times in a price band of Rs 420-446.
The issue was open for bidding from April 27-29.
The firm, which runs a diagnostics laboratory chain, has come out with a public issue of up to 10,744,708 shares.
The shares are proposed to be listed on the NSE and BSE.
JM Financial Institutional Securities, Edelweiss Financial Services and ICICI Securities managed the issue.
Thyrocare competes with diagnostics chains such as Dr Lal PathLabs, SRL Diagnostics, Metropolis Healthcare and Apollo Clinic.
Many healthcare firms like Alkem Laboratories, Dr Lal PathLabs and Narayana Hrudayalaya came out with their IPOs last year, while HealthCare Global Enterprises got listed on the stock exchanges in March.
More Like This
Published on May 8, 2016
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.